NOGUEIRA, R. G., M. M. QURESHI, M. ABDALKADER, S. O. MARTINS, H. YAMAGAMI, Z. M. QIU, O. Y. MANSOUR, A. SATHYA, A. CZLONKOWSKA, G. TSIVGOULIS, D. A. DE SOUSA, J. DEMEESTERE, Robert MIKULÍK, P. VANACKER, J. E. SIEGLER, J. KORV, J. BILLER, C. W. LIANG, N. S. SANGHA, A. M. ZHA, A. L. CZAP, C. A. HOLMSTEDT, T. N. TURAN, G. NTAIOS, K. MALHOTRA, A. TAYAL, A. LOOCHTAN, A. RANTA, E. A. MISTRY, A. W. ALEXANDROV, D. Y. HUANG, S. YAGHI, E. RAZ, S. A. SHETH, M. H. MOHAMMADEN, M. FRANKEL, E. G. B. LAMOU, H. M. AREF, A. ELBASSIOUNY, F. HASSAN, T. MENECIE, W. MUSTAFA, H. M. SHOKRI, T. ROUSHDY, F. S. SARFO, T. O. ALABI, B. ARABAMBI, E. O. NWAZOR, T. A. SUNMONU, K. WAHAB, J. YARIA, H. H. MOHAMMED, P. B. ADEBAYO, A. D. RIAHI a Sassi S. BEN. Global Impact of COVID-19 on Stroke Care and IV Thrombolysis. Neurology. Philadelphia: LIPPINCOTT WILLIAMS & WILKINS, 2021, roč. 96, č. 23, s. "E2824"-"E2838", 15 s. ISSN 0028-3878. Dostupné z: https://dx.doi.org/10.1212/WNL.0000000000011885.
Další formáty:   BibTeX LaTeX RIS
Základní údaje
Originální název Global Impact of COVID-19 on Stroke Care and IV Thrombolysis
Autoři NOGUEIRA, R. G., M. M. QURESHI, M. ABDALKADER, S. O. MARTINS, H. YAMAGAMI, Z. M. QIU, O. Y. MANSOUR, A. SATHYA, A. CZLONKOWSKA, G. TSIVGOULIS, D. A. DE SOUSA, J. DEMEESTERE, Robert MIKULÍK (203 Česká republika, garant, domácí), P. VANACKER, J. E. SIEGLER, J. KORV, J. BILLER, C. W. LIANG, N. S. SANGHA, A. M. ZHA, A. L. CZAP, C. A. HOLMSTEDT, T. N. TURAN, G. NTAIOS, K. MALHOTRA, A. TAYAL, A. LOOCHTAN, A. RANTA, E. A. MISTRY, A. W. ALEXANDROV, D. Y. HUANG, S. YAGHI, E. RAZ, S. A. SHETH, M. H. MOHAMMADEN, M. FRANKEL, E. G. B. LAMOU, H. M. AREF, A. ELBASSIOUNY, F. HASSAN, T. MENECIE, W. MUSTAFA, H. M. SHOKRI, T. ROUSHDY, F. S. SARFO, T. O. ALABI, B. ARABAMBI, E. O. NWAZOR, T. A. SUNMONU, K. WAHAB, J. YARIA, H. H. MOHAMMED, P. B. ADEBAYO, A. D. RIAHI a Sassi S. BEN.
Vydání Neurology, Philadelphia, LIPPINCOTT WILLIAMS & WILKINS, 2021, 0028-3878.
Další údaje
Originální jazyk angličtina
Typ výsledku Článek v odborném periodiku
Obor 30210 Clinical neurology
Stát vydavatele Spojené státy
Utajení není předmětem státního či obchodního tajemství
WWW URL
Impakt faktor Impact factor: 11.800
Kód RIV RIV/00216224:14110/21:00122752
Organizační jednotka Lékařská fakulta
Doi http://dx.doi.org/10.1212/WNL.0000000000011885
UT WoS 000702399700021
Klíčová slova anglicky COVID-19; Stroke Care; IV Thrombolysis
Štítky 14110127, rivok
Příznaky Mezinárodní význam, Recenzováno
Změnil Změnila: Mgr. Tereza Miškechová, učo 341652. Změněno: 8. 2. 2022 10:30.
Anotace
Objective To measure the global impact of COVID-19 pandemic on volumes of IV thrombolysis (IVT), IVT transfers, and stroke hospitalizations over 4 months at the height of the pandemic (March 1 to June 30, 2020) compared with 2 control 4-month periods. Methods We conducted a cross-sectional, observational, retrospective study across 6 continents, 70 countries, and 457 stroke centers. Diagnoses were identified by their ICD-10 codes or classifications in stroke databases. Results There were 91,373 stroke admissions in the 4 months immediately before compared to 80,894 admissions during the pandemic months, representing an 11.5% (95% confidence interval [CI] -11.7 to -11.3, p < 0.0001) decline. There were 13,334 IVT therapies in the 4 months preceding compared to 11,570 procedures during the pandemic, representing a 13.2% (95% CI -13.8 to -12.7, p < 0.0001) drop. Interfacility IVT transfers decreased from 1,337 to 1,178, or an 11.9% decrease (95% CI -13.7 to -10.3, p = 0.001). Recovery of stroke hospitalization volume (9.5%, 95% CI 9.2-9.8, p < 0.0001) was noted over the 2 later (May, June) vs the 2 earlier (March, April) pandemic months. There was a 1.48% stroke rate across 119,967 COVID-19 hospitalizations. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection was noted in 3.3% (1,722/52,026) of all stroke admissions. Conclusions The COVID-19 pandemic was associated with a global decline in the volume of stroke hospitalizations, IVT, and interfacility IVT transfers. Primary stroke centers and centers with higher COVID-19 inpatient volumes experienced steeper declines. Recovery of stroke hospitalization was noted in the later pandemic months.
Návaznosti
90128, velká výzkumná infrastrukturaNázev: CZECRIN III
VytisknoutZobrazeno: 5. 5. 2024 11:52